Content about Pharmaceuticals policy

November 12, 2012

The PBM division of CVS Caremark is hoping to get patients to use lower-cost drugs for certain conditions by removing higher-cost drugs from its formulary, according to published reports.

November 12, 2012

Procter & Gamble and Teva Pharmaceutical on Monday gained European Union approval for a joint venture on the sale of nonprescription medicines to be called PGT Healthcare, according to published reports.

November 9, 2012

Earlier this week, DSN reported that members of a prescription drug program offered by Humana to Medicare beneficiaries will soon be able to obtain 10 generic hypertension drugs from Walmart for a penny.

It's certainly good news for people with high blood pressure, but it also has big implications for the pharmacy retail industry.

November 8, 2012

Business for OTC store brands is expected to boom in the coming year, Perrigo chairman and CEO Joseph Papa told analysts discussing the private-label manufacturer's first quarter results during a conference call Wednesday, even as the growth rate across the entire OTC category slows.

November 7, 2012

A recent University of Cincinnati study suggested adolescent males are at a higher risk of reporting longtime abuse of over-the-counter drugs, compared with their female peers.

November 6, 2012

Pennsylvania Gov. Tom Corbett last week signed into law S.B. 201, a bill that takes critical steps toward leveling the playing field between large pharmacy benefit managers and the mail-order pharmacies they own and local, independent community pharmacies.

November 5, 2012

Industry leaders at an annual retail pharmacy conference in Canada got a look at a kiosk that allows patients to order prescription drugs through an Internet connection.

November 5, 2012

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

November 5, 2012

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.

November 1, 2012

Some generic drugs may come under more scrutiny from the Food and Drug Administration amid reports that the generic version of a treatment for depression didn't work as well as the branded version, according to published reports.

October 31, 2012

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

October 29, 2012

Par Pharmaceutical Cos. has bought rights to a generic version of a drug used to treat bipolar disorder and schizophrenia.

October 29, 2012

About 97% of online pharmacies are "rogue" operations operating outside U.S. laws and regulations, according to a new report.

October 29, 2012

The Food and Drug Administration has approved a Type 2 diabetes drug made by Watson Pharmaceuticals, the company said, following a federal court's order for the agency to approve the drug.

October 25, 2012

The Food and Drug Administration has approved a generic drug for leukemia made by a subsidiary of Par Pharmaceutical Cos.

October 24, 2012

Mylan is challenging a federal court decision ordering the Food and Drug Administration to allow Watson Pharmaceuticals to launch a generic diabetes drug, Mylan said.

October 23, 2012

The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

October 22, 2012

A group that lobbies on behalf of independent pharmacies is urging Pennsylvania Gov. Tom Corbett to sign a bill that would allow retail pharmacies to match the reimbursement terms, pricing and conditions that mail-order pharmacies negotiate exclusively with health insurance plans.

October 22, 2012

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

October 16, 2012

CVS Caremark has announced that it has reached a civil settlement with the United States Department of Justice regarding its investigation into certain business practices of a subsidiary of Longs Drug Stores, which began prior to the acquisition of Longs by CVS Caremark in October 2008.

October 16, 2012

The Federal Trade Commission has voted to approve Watson Pharmaceutical's acquisition of Switzerland-based generic drug maker Actavis.

October 16, 2012

Par Pharmaceutical Cos. has entered into agreements with Watson Pharmaceuticals and Actavis to purchase five generic products currently marketed in the United States by Watson or Actavis, eight abbreviated new drug applications currently awaiting regulatory approval, and a generic product in late-stage development.

October 16, 2012

Emerging multidisciplinary healthcare models, such as accountable care organizations and patient-centered medical homes, promise to elevate quality and lower costs by harnessing the power of provider, payer and patient collaboration. Often overlooked in the coordinated care equation, however, is the integral role pharmacists can play in delivering efficient and effective care.

October 15, 2012

With the start of Annual Enrollment Period on Monday for Medicare Part D prescription drug plans, CVS/pharmacy has announced that it is ready to help pharmacy patients who are enrolling in Medicare Part D for the first time or want to make a change to their current coverage plan.

© 2014 Drug Store News. All Rights Reserved.